Another Five-Minute Focus where we’re breaking down a study published in June 2024 in ACR Open Rheumatology on Metformin and it's potential cardiovascular and kidney-protective effects in patients with Systemic Lupus Erythematosus (SLE) and Lupus Nephritis.

Key Takeaways:

👉 Why Metformin?

📌 What This Means for Patients & Healthcare Professionals

📩 David from New York asks: "I have lupus but no diabetes. Could I ask my doctor about Metformin, or is it only for diabetic patients?"

If you need a medical writer with pharmacist expertise, contact me at innovationsmedicationm ...